Skip to main content
Top
Published in: BMC Medicine 1/2017

Open Access 01-12-2017 | Research article

The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies

Authors: Nicolas A. Menzies, Christian Suharlim, Fangli Geng, Zachary J. Ward, Logan Brenzel, Stephen C. Resch

Published in: BMC Medicine | Issue 1/2017

Login to get access

Abstract

Background

Evidence on immunization costs is a critical input for cost-effectiveness analysis and budgeting, and can describe variation in site-level efficiency. The Expanded Program on Immunization Costing and Financing (EPIC) Project represents the largest investigation of immunization delivery costs, collecting empirical data on routine infant immunization in Benin, Ghana, Honduras, Moldova, Uganda, and Zambia.

Methods

We developed a pooled dataset from individual EPIC country studies (316 sites). We regressed log total costs against explanatory variables describing service volume, quality, access, other site characteristics, and income level. We used Bayesian hierarchical regression models to combine data from different countries and account for the multi-stage sample design. We calculated output elasticity as the percentage increase in outputs (service volume) for a 1% increase in inputs (total costs), averaged across the sample in each country, and reported first differences to describe the impact of other predictors. We estimated average and total cost curves for each country as a function of service volume.

Results

Across countries, average costs per dose ranged from $2.75 to $13.63. Average costs per child receiving diphtheria, tetanus, and pertussis ranged from $27 to $139. Within countries costs per dose varied widely—on average, sites in the highest quintile were 440% more expensive than those in the lowest quintile. In each country, higher service volume was strongly associated with lower average costs. A doubling of service volume was associated with a 19% (95% interval, 4.0–32) reduction in costs per dose delivered, (range 13% to 32% across countries), and the largest 20% of sites in each country realized costs per dose that were on average 61% lower than those for the smallest 20% of sites, controlling for other factors. Other factors associated with higher costs included hospital status, provision of outreach services, share of effort to management, level of staff training/seniority, distance to vaccine collection, additional days open per week, greater vaccination schedule completion, and per capita gross domestic product.

Conclusions

We identified multiple features of sites and their operating environment that were associated with differences in average unit costs, with service volume being the most influential. These findings can inform efforts to improve the efficiency of service delivery and better understand resource needs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bishai D, McQuestion M, Chaudhry R, Wigton A. The costs of scaling up vaccination in the world's poorest countries. Health Affair. 2006;25(2):348–56.CrossRef Bishai D, McQuestion M, Chaudhry R, Wigton A. The costs of scaling up vaccination in the world's poorest countries. Health Affair. 2006;25(2):348–56.CrossRef
2.
go back to reference Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ. 2008;86(1):27–39.CrossRefPubMedPubMedCentral Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ. 2008;86(1):27–39.CrossRefPubMedPubMedCentral
3.
go back to reference Brenzel L. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries? Vaccine. 2015;33 Suppl 1:A93–98.CrossRefPubMed Brenzel L. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries? Vaccine. 2015;33 Suppl 1:A93–98.CrossRefPubMed
4.
go back to reference Robertson RL, Davis JH, Jobe K. Service volume and other factors affecting the costs of immunizations in the Gambia. Bull World Health Organ. 1984;62(5):729–36.PubMedPubMedCentral Robertson RL, Davis JH, Jobe K. Service volume and other factors affecting the costs of immunizations in the Gambia. Bull World Health Organ. 1984;62(5):729–36.PubMedPubMedCentral
5.
go back to reference Walker D, Mosqueira NR, Penny ME, Lanata CF, Clark AD, Sanderson CF, Fox-Rushby JA. Variation in the costs of delivering routine immunization services in Peru. Bull World Health Organ. 2004;82(9):676–82.PubMedPubMedCentral Walker D, Mosqueira NR, Penny ME, Lanata CF, Clark AD, Sanderson CF, Fox-Rushby JA. Variation in the costs of delivering routine immunization services in Peru. Bull World Health Organ. 2004;82(9):676–82.PubMedPubMedCentral
6.
go back to reference Creese AL, Sriyabbaya N, Casabal G, Wiseso G. Cost-effectiveness appraisal of immunization programmes. Bull World Health Organ. 1982;60(4):621–32.PubMedPubMedCentral Creese AL, Sriyabbaya N, Casabal G, Wiseso G. Cost-effectiveness appraisal of immunization programmes. Bull World Health Organ. 1982;60(4):621–32.PubMedPubMedCentral
7.
go back to reference Brenzel L, Young D, Walker DG. Costs and financing of routine immunization: approach and selected findings of a multi-country study (EPIC). Vaccine. 2015;33 Suppl 1:A13–20.CrossRefPubMed Brenzel L, Young D, Walker DG. Costs and financing of routine immunization: approach and selected findings of a multi-country study (EPIC). Vaccine. 2015;33 Suppl 1:A13–20.CrossRefPubMed
8.
go back to reference Schutte C, Chansa C, Marinda E, Guthrie TA, Banda S, Nombewu Z, Motlogelwa K, Lervik M, Brenzel L, Kinghorn A. Cost analysis of routine immunisation in Zambia. Vaccine. 2015;33 Suppl 1:A47–52.CrossRefPubMed Schutte C, Chansa C, Marinda E, Guthrie TA, Banda S, Nombewu Z, Motlogelwa K, Lervik M, Brenzel L, Kinghorn A. Cost analysis of routine immunisation in Zambia. Vaccine. 2015;33 Suppl 1:A47–52.CrossRefPubMed
9.
go back to reference Janusz CB, Castaneda-Orjuela C, Molina Aguilera IB, Felix Garcia AG, Mendoza L, Diaz IY, Resch SC. Examining the cost of delivering routine immunization in Honduras. Vaccine. 2015;33 Suppl 1:A53–59.CrossRefPubMed Janusz CB, Castaneda-Orjuela C, Molina Aguilera IB, Felix Garcia AG, Mendoza L, Diaz IY, Resch SC. Examining the cost of delivering routine immunization in Honduras. Vaccine. 2015;33 Suppl 1:A53–59.CrossRefPubMed
10.
go back to reference Goguadze K, Chikovani I, Gaberi C, Maceira D, Uchaneishvili M, Chkhaidze N, Gotsadze G. Costs of routine immunization services in Moldova: findings of a facility-based costing study. Vaccine. 2015;33 Suppl 1:A60–65.CrossRefPubMed Goguadze K, Chikovani I, Gaberi C, Maceira D, Uchaneishvili M, Chkhaidze N, Gotsadze G. Costs of routine immunization services in Moldova: findings of a facility-based costing study. Vaccine. 2015;33 Suppl 1:A60–65.CrossRefPubMed
11.
go back to reference Le Gargasson JB, Nyonator FK, Adibo M, Gessner BD, Colombini A. Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana. Vaccine. 2015;33 Suppl 1:A40–46.CrossRefPubMed Le Gargasson JB, Nyonator FK, Adibo M, Gessner BD, Colombini A. Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana. Vaccine. 2015;33 Suppl 1:A40–46.CrossRefPubMed
12.
go back to reference Ahanhanzo CD, Huang XX, Le Gargasson JB, Sossou J, Nyonator F, Colombini A, Gessner BD. Determinants of routine immunization costing in Benin and Ghana in 2011. Vaccine. 2015;33 Suppl 1:A66–71.CrossRefPubMed Ahanhanzo CD, Huang XX, Le Gargasson JB, Sossou J, Nyonator F, Colombini A, Gessner BD. Determinants of routine immunization costing in Benin and Ghana in 2011. Vaccine. 2015;33 Suppl 1:A66–71.CrossRefPubMed
13.
go back to reference Maceira D, Goguadze K, Gotsadze G. The drivers of facility-based immunization performance and costs. An application to Moldova. Vaccine. 2015;33 Suppl 1:A72–78.CrossRefPubMed Maceira D, Goguadze K, Gotsadze G. The drivers of facility-based immunization performance and costs. An application to Moldova. Vaccine. 2015;33 Suppl 1:A72–78.CrossRefPubMed
14.
go back to reference Valdes W, Janusz CB, Molina Aguilera IB, Mendoza L, Diaz IY, Resch S. Tracking financial flows for immunization in Honduras. Vaccine. 2015;33 Suppl 1:A85–92.CrossRefPubMed Valdes W, Janusz CB, Molina Aguilera IB, Mendoza L, Diaz IY, Resch S. Tracking financial flows for immunization in Honduras. Vaccine. 2015;33 Suppl 1:A85–92.CrossRefPubMed
15.
go back to reference Guthrie T, Zikusooka C, Kwesiga B, Abewe C, Lagony S, Schutte C, Marinda E, Humphreys K, Motlogelwa K, Nombewu ZC, et al. Mapping financial flows for immunisation in Uganda 2009/10 and 2010/11: new insights for methodologies and policy. Vaccine. 2015;33 Suppl 1:A79–84.CrossRefPubMed Guthrie T, Zikusooka C, Kwesiga B, Abewe C, Lagony S, Schutte C, Marinda E, Humphreys K, Motlogelwa K, Nombewu ZC, et al. Mapping financial flows for immunisation in Uganda 2009/10 and 2010/11: new insights for methodologies and policy. Vaccine. 2015;33 Suppl 1:A79–84.CrossRefPubMed
16.
go back to reference WHO Global Health Observatory. Diphtheria tetanus toxoid and pertussis (DTP3) data by country: Global Health Observatory Data Repository. World Health Organisation; 2015. WHO Global Health Observatory. Diphtheria tetanus toxoid and pertussis (DTP3) data by country: Global Health Observatory Data Repository. World Health Organisation; 2015.
18.
go back to reference Brenzel L. Common approach for the costing and financing of routine immunization and new vaccines (EPIC), working paper. Washington DC: Bill & Melinda Gates Foundation; 2014. Brenzel L. Common approach for the costing and financing of routine immunization and new vaccines (EPIC), working paper. Washington DC: Bill & Melinda Gates Foundation; 2014.
20.
go back to reference Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276(15):1253–8.CrossRefPubMed Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276(15):1253–8.CrossRefPubMed
21.
go back to reference Hoffman MD, Gelman A. The No-U-Turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. J Mach Learn Res. 2012;15(1):1593–623. Hoffman MD, Gelman A. The No-U-Turn sampler: adaptively setting path lengths in Hamiltonian Monte Carlo. J Mach Learn Res. 2012;15(1):1593–623.
23.
go back to reference R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
24.
go back to reference Gelman A, Hwang J, Vehtari A. Understanding predictive information criteria for Bayesian models. Stat Comput. 2014;24:997–1016.CrossRef Gelman A, Hwang J, Vehtari A. Understanding predictive information criteria for Bayesian models. Stat Comput. 2014;24:997–1016.CrossRef
25.
go back to reference Vehtari A, Gelman A. WAIC and cross-validation in Stan. Helsinki: Aalto University; 2014. Vehtari A, Gelman A. WAIC and cross-validation in Stan. Helsinki: Aalto University; 2014.
26.
go back to reference Duan N. Smearing estimate: a nonparametric retransformation method. JASA. 1983;78:605–10.CrossRef Duan N. Smearing estimate: a nonparametric retransformation method. JASA. 1983;78:605–10.CrossRef
27.
go back to reference O’Hagan A. On outliers rejection phenomena in Bayes inference. J R Stat Soc B. 1979;41:358–67. O’Hagan A. On outliers rejection phenomena in Bayes inference. J R Stat Soc B. 1979;41:358–67.
28.
go back to reference Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.CrossRefPubMed Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461–94.CrossRefPubMed
29.
Metadata
Title
The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies
Authors
Nicolas A. Menzies
Christian Suharlim
Fangli Geng
Zachary J. Ward
Logan Brenzel
Stephen C. Resch
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2017
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-017-0942-1

Other articles of this Issue 1/2017

BMC Medicine 1/2017 Go to the issue